Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLOTILDIA: Ticagrelor vs Clopidogrel in Diabetic PCI Patients
NCT02742987Phase 4Completed
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Mar 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of ticagrelor in coronary artery disease (CAD) (2 arms), sponsored by Università Campus Bio-Medico di Roma. Primary endpoint: Flow-mediated Dilation of the Brachial Artery at 4 weeks. Started Mar 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02742987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02742987.